Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 670 results found. Search for [ global drug company ]

Results 1 to 21 of 670
BusinessToday.In
December 3, 2019
Siddharth Mittal has been a core member of Biocon's leadership team since May 2013. He has been serving as the Chief Financial Officer of the company since August 2014


E Kumar Sharma
December 2, 2019
Earlier this month, AstraZeneca announced three large-scale initiatives to build on the company's long-standing commitment to China and advance global R&D for innovative new medicines


BusinessToday.In
November 29, 2019
Aurobindo Pharma share price gained 2.67% to Rs 462.2 compared to the previous close of Rs 450.20 on BSE


BusinessToday.In
New Delhi, November 28, 2019
HDFC Bank shares will be in focus after the lender said it has constituted a six-member search committee to replace Aditya Puri as managing director and chief executive officer of the bank, whose tenure ends on October 26, 2020


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


E Kumar Sharma
New Delhi, November 25, 2019
Rajiv Malik, President, Mylan, speaks about the impact the deal will have on India operations, the challenges in generic drugs and the role that China will play


Team BT
November 13, 2019



PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
New Delhi, November 7, 2019
Sun Pharma Q2 results: India sales, which accounted for 31.6 per cent of total consolidated sales, rose 35 per cent year-on-year (YoY) to Rs 2,515 crore in September quarter of this fiscal


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
New Delhi, November 6, 2019
Lupin Q2 results: Consolidated revenue from operations of the pharma major increased 10.3 per cent year-on-year (YoY) to Rs 4,359.7 crore in Q2FY20 as against Rs 3,951 crore in Q2FY19


BusinessToday.In
New Delhi, November 6, 2019
Cipla Q2 results: Consolidated revenue from India business grew 9 per cent yoy to Rs 1,810 crore, while international business delivered a growth of 8 per cent yoy at Rs 2,454 crore


PB Jayakumar
New Delhi, October 30, 2019
Robots are changing the world of surgery, including in India


Manu Kaushik
New Delhi, October 30, 2019
Even though Gangwal stands on thin ice if the powers entrusted in the shareholders' agreement are considered; Bhatia has much more to lose if this matter escalates further


Joe C Mathew
New Delhi, October 30, 2019
The spectacular rise of a reticent man who has pushed his company to the top but still avoids media glare and limelight


Reuters
Washington, October 25, 2019
Last week, J&J recalled around 33,000 bottles of baby powder in the United States after the health regulators found trace amounts of asbestos in samples taken from a bottle purchased online


PTI
October 25, 2019



Reuters
October 19, 2019
The recall is the latest blow to the more than 130-year-old US healthcare conglomerate that is facing thousands of lawsuits over a variety of products, including baby powder, opioids, medical devices and the antipsychotic Risperdal.


PTI
October 9, 2019



PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


PAGES 1 OF 34  12345